EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study

Michael Haude, Adrian Wlodarczak, René J van der Schaaf, Jan Torzewski, Bert Ferdinande, Javier Escaned, Juan F Iglesias, Johan Bennett, Gabor G Toth, Michael Joner, Ralph Toelg, Marcus Wiemer und 4 weitere

EuroIntervention · 2023-08 · 19 (5) · e414-e422

DOI: 10.4244/eij-d-23-00326 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift EuroIntervention, 2023-08. Verfasst von Michael Haude und 15 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany. Hauptthemen laut MEDLINE: Coronary Artery Disease, Drug-Eluting Stents, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The third-generation coronary sirolimus-eluting magnesium scaffold, DREAMS 3G, is a further development of the DREAMS 2G (commercial name Magmaris), aiming to provide performance outcomes similar to drug-eluting stents (DES). AIMS: The BIOMAG-I study aims to assess the safety and performance of this new-generation scaffold. METHODS: This is a prospective, multicentre, first-in-human study with clinical and imaging follow-up scheduled at 6 and 12 months. The clinical follow-up will continue for 5 years. RESULTS: A total of 116 patients with 117 lesions were enrolled. At 12 months, after completion of resorption, in-scaffold late lumen loss was 0.24±0.36 mm (median 0.19, interquartile range 0.06-0.36). The minimum lumen area was 4.95±2.24 mm² by intravascular ultrasound and 4.68±2.32 mm² by optical coherence tomography. Three target lesion failures were reported (2.6%, 95% confidence interval: 0.9-7.9), all clinically driven target lesion revascularisations. Cardiac death, target vessel myocardial infarction and definite or probable scaffold thrombosis were absent. CONCLUSIONS: Data at the end of the resorption period of DREAMS 3G showed that the third-generation bioresorbable magnesium scaffold is clinically safe and effective, making it a possible alternative to DES. CLINICALTRIALS: gov: NCT04157153.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseDrug-Eluting StentsPercutaneous Coronary InterventionHumansAbsorbable ImplantsCoronary AngiographyMagnesiumProspective StudiesTreatment Outcome

Substanzen

Magnesium

Autor:innen und Institutionen

  • Medical Clinic I, Rheinland Klinikum Neuss GmbH, Lukaskrankenhaus, Neuss, Germany.
  • Department of Cardiology, Miedziowe Centrum Zdrowia SA, Lubin, Poland.
  • Department of Interventional Cardiology, OLVG, Amsterdam, the Netherlands.
  • Cardiovascular Center Oberallgäu-Kempten, Kempten, Germany.
  • Department of Cardiology, Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.
  • Division of Cardiology, Hospital Clinico San Carlos IdISSC, Complutense University of Madrid, Madrid, Spain.

Zitieren

APA

Haude, M., Wlodarczak, A., van der Schaaf, R. J., Torzewski, J., Ferdinande, B., Escaned, J., Iglesias, J. F., Bennett, J., Toth, G. G., Joner, M., Toelg, R., Wiemer, M., Olivecrano, G., Vermeersch, P., Garcia-Garcia, H. M., & Waksman, R. (2023). A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention, 19(5), e414-e422. https://doi.org/10.4244/eij-d-23-00326

Vancouver

Haude M, Wlodarczak A, van der Schaaf RJ, Torzewski J, Ferdinande B, Escaned J, et al. A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study. EuroIntervention. 2023;19(5):e414-e422. doi:10.4244/eij-d-23-00326

BibTeX
@article{Haude2023,
  author = {Haude, Michael and Wlodarczak, Adrian and van der Schaaf, René J and Torzewski, Jan and Ferdinande, Bert and Escaned, Javier and Iglesias, Juan F and Bennett, Johan and Toth, Gabor G and Joner, Michael and Toelg, Ralph and Wiemer, Marcus and Olivecrano, Göran and Vermeersch, Paul and Garcia-Garcia, Hector M and Waksman, Ron},
  title = {A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study},
  journal = {EuroIntervention},
  year = {2023},
  volume = {19},
  number = {5},
  pages = {e414--e422},
  doi = {10.4244/eij-d-23-00326}
}
Kostenlos starten →